← 홈

난소암 · HER2

5개 · ADC 1048 · Antibody 5323 · CGT 2737 · 다음 갱신 D-13 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 5개
ADCBiologicstaleRemeGen Co., Ltd.Phase 2

disitamab vedotin (Disitamab Vedotin, RC48, RC48 + Carboplatin)

Ovarian Cancer; HER2 · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 11상태 RECRUITING
CGTBiologicstaleZhi YangPhase 2

Anti-HER2 CAR-T (Anti-HER2 CAR-T)

Breast Cancer; Ovarian Cancer · HER2

#HER2#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 DISCONTINUED
ADCBiologicstaleSeagen, a wholly owned subsidia…Phase 1

Felmetatug Vedotin (Felmetatug Vedotin)

Ovarian Neoplasms; Peritoneal Neoplasms · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 DISCONTINUED
AntibodystaleNeoTX Therapeutics Ltd.Phase 1

durvalumab (Imfinzi, Naptumomab estafenatox and durvalumab)

ER+ Breast Cancer; Ovarian Cancer · HER2

#HER2#Antibody#Phase1#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 1

durvalumab (Imfinzi, Obinutuzumab, naptumomab estafenatox and durvalumab)

ER+ Breast Cancer; Ovarian Cancer · HER2

#HER2#Antibody#Phase1#항체#면역항체+4
임상시험 1상태 RECRUITING